Protocol No
ANTHOS-ANT-007
Staff Member
Lisa Baumann Kreuziger
Phase
III
Summary
This project is being done to see if patients taking the study drug Abelacimab have fewer bleeding events compared to those taking Apixaban for the treatment of venous thromboembolism (VTE) while receiving treatment for cancer.
Objective
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE (ASTER)
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
Cancer,
Eye/Orbital Cancers,
Skin Cancers,
Cervix,
Lip, Oral Cavity and Pharynx,
Sarcoma,
Other Gastrointestinal,
Other Blood Related,
Pancreas/Liver,
Uterine,
Other Respiratory,
Gynecologic Cancers,
Brain and Spine Cancers,
Bladder,
Lung,
Head and Neck Cancers,
Leukemia,
Prostate,
Esophagus,
Thoracic Cancers,
Colorectal,
Hematologic/Blood Related Cancers,
Gastrointestinal Cancers,
Kidney,
Endocrine Cancers,
Prostate and Urologic Cancers,
Multiple Myeloma,
Breast Cancers
ClinicalTrials.gov